ATE224387T1 - N-(pyridinylamino)isoindoline und verwandte verbindungen - Google Patents
N-(pyridinylamino)isoindoline und verwandte verbindungenInfo
- Publication number
- ATE224387T1 ATE224387T1 AT97948250T AT97948250T ATE224387T1 AT E224387 T1 ATE224387 T1 AT E224387T1 AT 97948250 T AT97948250 T AT 97948250T AT 97948250 T AT97948250 T AT 97948250T AT E224387 T1 ATE224387 T1 AT E224387T1
- Authority
- AT
- Austria
- Prior art keywords
- isoindolines
- pyridinylamino
- related compounds
- intermediates
- compositions
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 239000000543 intermediate Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- FRDNVRYBEXCNBP-UHFFFAOYSA-N n-pyridin-2-yl-1,3-dihydroisoindol-2-amine Chemical class C1C2=CC=CC=C2CN1NC1=CC=CC=N1 FRDNVRYBEXCNBP-UHFFFAOYSA-N 0.000 abstract 2
- 230000007074 memory dysfunction Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
- C07D213/77—Hydrazine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77430896A | 1996-12-27 | 1996-12-27 | |
| US08/959,789 US6004977A (en) | 1996-12-27 | 1997-10-29 | N-(pyridinylamino) isoindolines and related compounds |
| PCT/US1997/020591 WO1998029407A2 (en) | 1996-12-27 | 1997-11-13 | N-(pyridinylamino)isoindolines for treating alzheimer's and depression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE224387T1 true ATE224387T1 (de) | 2002-10-15 |
Family
ID=27118867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97948250T ATE224387T1 (de) | 1996-12-27 | 1997-11-13 | N-(pyridinylamino)isoindoline und verwandte verbindungen |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0950056B1 (de) |
| JP (1) | JP4256937B2 (de) |
| KR (1) | KR20000062358A (de) |
| AT (1) | ATE224387T1 (de) |
| AU (1) | AU720466B2 (de) |
| BR (1) | BR9714189A (de) |
| CA (1) | CA2276203C (de) |
| DE (1) | DE69715668T2 (de) |
| DK (1) | DK0950056T3 (de) |
| ES (1) | ES2179377T3 (de) |
| HU (1) | HUP0000783A2 (de) |
| IL (1) | IL130642A0 (de) |
| NO (1) | NO993180L (de) |
| PT (1) | PT950056E (de) |
| WO (1) | WO1998029407A2 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6772195B1 (en) | 1999-10-29 | 2004-08-03 | Electronic Arts, Inc. | Chat clusters for a virtual world application |
| EP1283199A4 (de) * | 2000-05-16 | 2003-12-17 | Takeda Chemical Industries Ltd | Antagonisten des melanin-konzentrierenden hormons |
| KR20060009686A (ko) * | 2004-07-26 | 2006-02-01 | 엘지이노텍 주식회사 | 반도체 발광소자 및 그 제조방법 |
| US9623021B2 (en) | 2007-01-22 | 2017-04-18 | Gtx, Inc. | Nuclear receptor binding agents |
| US9604931B2 (en) | 2007-01-22 | 2017-03-28 | Gtx, Inc. | Nuclear receptor binding agents |
| KR101638035B1 (ko) | 2007-01-22 | 2016-07-11 | 지티엑스, 인코포레이티드 | 핵 수용체에 결합하는 물질 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3852335T2 (de) * | 1987-04-24 | 1995-05-11 | Hoechst Roussel Pharma | N-(Pyridinyl)-1H-indol-1-amine, Verfahren zu deren Herstellung und ihre Verwendung als Arzneimittel. |
| US5006537A (en) * | 1989-08-02 | 1991-04-09 | Hoechst-Roussel Pharmaceuticals, Inc. | 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones |
| DK0415103T3 (da) * | 1989-08-02 | 1995-06-19 | Hoechst Roussel Pharma | 2,3-Dihydro-1-(pyridinylamino)-indoler, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler |
| US5102891A (en) * | 1990-07-23 | 1992-04-07 | Hoechst-Roussel Pharmaceuticals Inc. | 1-(substituted pyridinylamino)-1H-indol-5-yl substituted carbamates |
| US5177088A (en) * | 1991-04-17 | 1993-01-05 | Hoechst-Roussel Pharmaceuticals Incorporated | Substituted 3-(pyridinylamino)-indoles |
| US5328920A (en) * | 1991-04-17 | 1994-07-12 | Hoechst-Roussel Pharmaceuticals Incorporated | Substituted (pyridinylamino)-indoles |
-
1997
- 1997-11-13 DE DE69715668T patent/DE69715668T2/de not_active Expired - Fee Related
- 1997-11-13 BR BR9714189-5A patent/BR9714189A/pt not_active IP Right Cessation
- 1997-11-13 CA CA002276203A patent/CA2276203C/en not_active Expired - Fee Related
- 1997-11-13 HU HU0000783A patent/HUP0000783A2/hu unknown
- 1997-11-13 EP EP97948250A patent/EP0950056B1/de not_active Expired - Lifetime
- 1997-11-13 JP JP52999098A patent/JP4256937B2/ja not_active Expired - Fee Related
- 1997-11-13 IL IL13064297A patent/IL130642A0/xx unknown
- 1997-11-13 DK DK97948250T patent/DK0950056T3/da active
- 1997-11-13 AU AU54349/98A patent/AU720466B2/en not_active Ceased
- 1997-11-13 AT AT97948250T patent/ATE224387T1/de not_active IP Right Cessation
- 1997-11-13 PT PT97948250T patent/PT950056E/pt unknown
- 1997-11-13 WO PCT/US1997/020591 patent/WO1998029407A2/en not_active Ceased
- 1997-11-13 ES ES97948250T patent/ES2179377T3/es not_active Expired - Lifetime
- 1997-11-13 KR KR1019997005846A patent/KR20000062358A/ko not_active Abandoned
-
1999
- 1999-06-25 NO NO993180A patent/NO993180L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2276203C (en) | 2003-07-22 |
| WO1998029407A3 (en) | 1998-10-22 |
| IL130642A0 (en) | 2000-06-01 |
| NO993180L (no) | 1999-08-26 |
| EP0950056A2 (de) | 1999-10-20 |
| ES2179377T3 (es) | 2003-01-16 |
| KR20000062358A (ko) | 2000-10-25 |
| DK0950056T3 (da) | 2003-01-27 |
| DE69715668T2 (de) | 2003-07-31 |
| AU720466B2 (en) | 2000-06-01 |
| CA2276203A1 (en) | 1998-07-09 |
| AU5434998A (en) | 1998-07-31 |
| BR9714189A (pt) | 2000-02-29 |
| NO993180D0 (no) | 1999-06-25 |
| PT950056E (pt) | 2002-12-31 |
| HUP0000783A2 (hu) | 2001-04-28 |
| JP2001511119A (ja) | 2001-08-07 |
| EP0950056B1 (de) | 2002-09-18 |
| WO1998029407A2 (en) | 1998-07-09 |
| DE69715668D1 (de) | 2002-10-24 |
| JP4256937B2 (ja) | 2009-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69830072D1 (de) | Radioaktive zusammensetzungen zur behandlung von prostatatumoren | |
| DE69729877D1 (de) | Mycophenol bisphosponatverbindungen | |
| BR9707819A (pt) | Imunogenos peptidicos | |
| AU9102198A (en) | Indole-3-carbinol, diindolylmethane and substituted analogs as antiestrogens | |
| ATE177420T1 (de) | Cyclobutan-derivate als inhibitoren der squalen- synthetase und der protein-farnesyltransferase | |
| NO20006645D0 (no) | Ny form av irbesartan, fremgangsmåte for å oppnå den nevnte form og farmasöytiske preparater inneholdende den samme | |
| BG104780A (en) | Inhibitors of phospholipase enzymes | |
| ATE304358T1 (de) | (s,s)-reboxetin zur behandlung von migränekopfschmerzen | |
| PT966465E (pt) | Inibidores do enzima imfdh | |
| MX9703564A (es) | Inhibidores de proteasa multicatalitica. | |
| DE69807115D1 (de) | Angiostatische verbindungen und zusammensetzungen zur behandlung des glc1a glaukoms | |
| BG105028A (en) | Bridged indenopyrrolocarbazoles | |
| TR200001012T2 (tr) | Yeni ariloksi-alkil-dialkilaminler. | |
| DE69905476D1 (en) | Phosphonsaürederivate als ptp-1b-inhibitoren | |
| MX9604367A (es) | Hidroxipiridinonas novedosas. | |
| DE69937301D1 (de) | Aminosterolderivate und ihre verwendungen | |
| ES2088128T3 (es) | Aminosulfonilureas inhibidoras de acat. | |
| DK0996435T3 (da) | Aminosyrederivater anvendelige til behandling af slagtilfælde | |
| DE69715668D1 (de) | N-(pyridinylamino)isoindoline und verwandte verbindungen | |
| WO1988003927A3 (en) | Renin inhibitors | |
| NO943765L (no) | Aryloksybenzen-herbicidmidler | |
| ATE247955T1 (de) | Selenophen-antitumormittel | |
| DK0720597T3 (da) | Triarylethylenderivater til terapeutisk anvendelse | |
| NO990436L (no) | FremgangsmÕte for behandling av bipolar forstyrrelse | |
| NZ505085A (en) | Pharmaceutical compositions comprising bipapcitide monocarboxylate and/or bipapcitide dicarboxylate for imaging and treating thrombi |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0950056 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |